Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply | Pharmaceuticals industry
The explosion in demand for the weight-loss drug Wegoby has prompted the holding company of its maker, Novo Nordisk, to buy the US-based drug giant for $16.5 billion ($12.70) and end its production capacity. Novo Holdings has acquired New Jersey-based pharmaceutical company Catalent, which it plans to immediately sell three of its locations in the […]
Ozempic and Wegovy maker Novo Nordisk now worth $500B
The soaring popularity of weight-loss drugs Ozempic and Wigovy has pushed parent company Novo Nordisk’s valuation past the $5 trillion threshold, according to the report. The Danish drug company, which originally sold the drug as a treatment for diabetes, was valued at $506 billion. According to CNBCanalyzed data from the London Stock Exchange Group. Novo […]
Ozempic and Wegovy overdose calls have spiked, experts say
As the popularity of the weight loss drug semaglutide grows, experts warn that the rate of potentially dangerous overdoses is also increasing. Reports of overdoses for semaglutide products such as Ozempic and Wigovy more than doubled between 2022 and 2023, according to the American Poison Center in Virginia. “U.S. Poison Centers have recorded 3,316 exposures […]